Skip to main content

Prostate and Urologic Cancers

Conducts and supports research on the prevention and early detection of prostate and bladder cancers. Develops and supports prevention trials and evaluation of new agents, surrogate biomarkers, and emerging technologies for identifying premalignant lesions.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	Asefa, Mela mela.asefa@nih.gov 240-276-6422	5E328	Program Support Assistant \| Breast and Gynecologic Cancer Program Support Assistant \| Prostate and Urologic Cancer
	House, Margaret, RN, B.S.N. margaret.house@nih.gov 240-276-7047	5E306	Deputy Chief \| Prostate and Urologic Cancer
	Parnes, Howard L., M.D. howard.parnes@nih.gov 240-276-7045	5E302	Chief \| Prostate and Urologic Cancer

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Kirkwood, Kimberly Saunders	University Of California, San Francisco United States	Using microvolumetric cyst fluid proteolysis for early detection of pancreatic cancer	5U01CA282269-02	Matthew Young, Ph.D.
Kisiel, John	Mayo Clinic Rochester United States	Multi-cancer Early Detection	2R01CA214679-08	Matthew Young, Ph.D.
Kleckner, Amber Simmons	University Of Maryland Baltimore United States	Time-restricted eating to address cancer-related fatigue among survivors of hematological malignancies	5R01CA284082-02	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Klein, Alison P	Johns Hopkins University United States	Improving Management of patients at High Risk of Pancreatic Cancer	1R01CA299421-01	Matthew Young, Ph.D.
Klopp, Ann	University Of Tx Md Anderson Can Ctr United States	Defining a globally accessible and pragmatic predictive signature (GAPPS) for locally advanced cervical cancer	1R01CA301124-01	Goli Samimi, Ph.D., M.P.H.
Knoerl, Robert James	University Of Michigan At Ann Arbor United States	Determining the Feasibility of Virtual Tailored, Music-Based Relaxation for Anxiety Among Adolescent and Young Adult Cancer Survivors.	5R34CA286712-02	Goli Samimi, Ph.D., M.P.H.
Kober, Kord Michael	University Of California, San Francisco United States	An Investigation of the Molecular Mechanisms for and Prediction of the Severity of Cancer Chemotherapy-Related Fatigue Using a Multi-staged Integrated Omics Approach	5R37CA233774-07	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Kolb, Noah Allan	University Of Vermont & St Agric College United States	Remote Monitoring of Management of Chemotherapy induced Peripheral Neuropathy	5R01CA247517-05	Brennan Streck, Ph.D., RN, M.P.H.
Kong, Mei	University Of California-Irvine United States	Using dietary glutamine supplementation for melanoma prevention and targeted therapy	5R01CA244360-05	Gabriela Riscuta, M.D., CNS
Kooperberg, Charles L	Fred Hutchinson Cancer Center United States	Statistics and Data Management Center (SDMC) for the NCI Cancer Screening Research Network (CSRN)	5UG1CA287013-02	Elyse LeeVan, M.D., M.P.H.
Kresty, Laura A	University Of Michigan At Ann Arbor United States	Developing Natural Products to Target IL-8 Signaling and Intercept Progression of Barrett’s Esophagus to Esophageal Adenocarcinoma	1UG3CA299397-01	Altaf Mohammed, Ph.D.
Krist, Alexander H	Virginia Commonwealth University United States	Virginia Cancer Screening Research Network Access Hub (Virginia CSRN Hub)	3UG1CA287017-02S1	Elyse LeeVan, M.D., M.P.H.
Kroetz, Deanna L	Ohio State University United States	Sphingolipid Signaling and Chemotherapy-Induced Peripheral Neurotoxicity	5R01CA261068-06	Rachel Altshuler, Ph.D.
Kuhn, Peter	University Of Southern California United States	Multi-modal Liquid Biopsy Early Assessment of Breast Cancer, Pancreatic Cancer, and Multiple Myeloma	4U01CA285013-03	Nicholas Hodges, Ph.D.
Kumar, Nagi B.	H. Lee Moffitt Cancer Ctr & Res Inst United States	Phase II Clinical trial of GTC in Men on Active Surveillance	5R01CA235032-06	Howard L. Parnes, M.D.